Epidemiology and Clinical Manifestations of Individuals Presenting to St Vincent's Emergency Department From Victorian Correctional Facilities: An Observational Study
Abstract
Introduction: The incarcerated population in Australia has grown substantially, with individuals in prison experiencing complex health needs and barriers to accessing timely healthcare. Despite these challenges, there is limited data on the reasons incarcerated individuals present to EDs. This study aims to describe the characteristics, clinical presentations and outcomes of correctional patients presenting to a tertiary ED.
Methods: This retrospective study included individuals flagged as incarcerated in the hospital's electronic medical records who presented to St Vincent's Emergency Department (Victoria, Australia) between 1 January 2014 and 31 December 2023 and a case series of ICU-admitted incarcerated individuals.
Results: A total of 10,682 ED presentations were recorded from 5890 unique incarcerated individuals. Their median age was 35 years (interquartile range = 17). Most were male (85.1%), most were non-Indigenous (79.2%), with 9.2% identifying as First Nations people. The proportion of correctional patients who identified as First Nations people increased from 5.1% in 2014 to 13.6% in 2023, indicating an average annual increase of approximately 17%. Female First Nations people were disproportionally represented in this study compared to their non-Indigenous counterparts (20.0% vs. 14.9%, p = 0.002). Forty-four presentations from correctional centres were admitted to the intensive care unit (ICU). Most presentations to the ED were discharged to correctional…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 5,890 participants or records.
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.